StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.96+0.00 (0.00%)

Close on Nov 13, 2026Market cap $59.76MP/E –Yield –

XBiotech profit margin

Profit margin (net margin) is net income as a percentage of revenue.

XBiotech's profit margin for the twelve months ending Sep 30, 2023 was -7708.3%. For fiscal 2022 it was -820.4%, against -94.7% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 2022-820.4%−725.8
FY2021Dec 31, 2021-94.7%−69.2
FY2020Dec 31, 2020-25.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2022Dec 31, 2022-1067.7%−924.0
Q3 FY2022Sep 30, 2022-753.5%−681.3
Q2 FY2022Jun 30, 2022-761.0%−647.9
Q1 FY2022Mar 31, 2022-1079.0%−1026.1
Q4 FY2021Dec 31, 2021-143.7%−108.8
Q3 FY2021Sep 30, 2021-72.2%−48.2
Q2 FY2021Jun 30, 2021-113.1%−68.9
Q1 FY2021Mar 31, 2021-52.9%−52.8
Q4 FY2020Dec 31, 2020-34.9%–
Q3 FY2020Sep 30, 2020-23.9%–
Q2 FY2020Jun 30, 2020-44.2%–
Q1 FY2020Mar 31, 2020-0.1%–

More XBiotech figures

See a number that looks wrong?